|
26 Apr 2007 |
ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic Testing of ANX-514 (Docetaxel Emulsion)
|
|
26 Apr 2007 |
BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
|
|
26 Apr 2007 |
Dr. Reddy's Announces the Launch of Zolpidem Tartrate Tablets
|
|
26 Apr 2007 |
OctoPlus obtains full rights to PolyActive drug delivery technology from IsoTis
|
|
25 Apr 2007 |
Beyond biogenerics: the real threats for therapeutic proteins
|
|
25 Apr 2007 |
Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
|
|
25 Apr 2007 |
Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
|
|
25 Apr 2007 |
Wockhardt receives US FDA approval for anti-hypertensive drug
|
|
25 Apr 2007 |
Sciele Pharma to Acquire Alliant Pharmaceuticals, a Pediatric Specialty Pharmaceutical Company
|
|
24 Apr 2007 |
AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15.2 billion
|
|
24 Apr 2007 |
Alimera Sciences' Medidur(TM) Trial Exceeds 500 Patient Mark In Phase 3 Trial Enrollment
|
|
24 Apr 2007 |
Synosia Therapeutics Announces Second Major Pharmaceutical Deal
|
|
24 Apr 2007 |
KaloBios Licenses Humaneering(TM) Technology to Major Pharmaceutical Company
|
|
24 Apr 2007 |
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
|
|
24 Apr 2007 |
Caraco Pharmaceutical Laboratories Ltd. Announces FDA Approval to Market Generic Ambien(R)
|
|
24 Apr 2007 |
Prasco Enters into Agreement with sanofi-aventis to Market the Authorized Generic Versions of Ambien(R) (Zolpidem Tartrate) CIV
|
|
24 Apr 2007 |
Vectura Announces Successful Outcome of Second Phase IIb Clinical Study on Inhaled Erectile Dysfunction Product
|
|
23 Apr 2007 |
AstraZeneca to Acquire MedImmune For $58 Per Share in a Fully Recommended, All-cash Transaction with a Total Enterprise Value of $15.2 Billion
|
|
21 Apr 2007 |
FDA Grants Full Approval for DepoCyt(R) for the Treatment of Lymphomatous Meningitis
|
|
21 Apr 2007 |
Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
|
|
20 Apr 2007 |
Novacea Acquires Worldwide Development and Commercialization Rights for Its Oncology Candidate AQ4N
|
|
20 Apr 2007 |
Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals
|
|
20 Apr 2007 |
Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals
|
|
19 Apr 2007 |
Completion of Phase I Trial on the Anti-influenza Drug CS-8958
|
|
19 Apr 2007 |
Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
|
